An inactivated COVID-19 vaccine developed by Sinopharm's Wuhan institute became the third vaccine to enter the market in China on Sunday, Hubei Daily reported.
The institute has a production capacity of 100 million doses per year, the report said.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3